Serán BioScience

Can your formulation strategy survive scale-up? “Fast” formulation development is meaningless if the process breaks later. Biotech teams today are under pressure to: • Reach IND faster • Conserve API • Reduce burn • Generate clinical data quickly But compressing timelines without considering commercial manufacturability often creates bigger delays downstream. At Serán BioScience, we believe speed and scalability should be designed together from day one. Contact our team to learn more https://lnkd.in/g9JRJiHX #PharmaceuticalDevelopment #CDMO #CMC #DrugManufacturing #Biopharma

Can your formulation strategy survive scale-up? “Fast” formulation development is meaningless if the process breaks later. Biotech teams today are under pressure to: • Reach IND faster • Conserve API • Reduce burn • Generate clinical data quickly But compressing timelines without considering commercial manufacturability often creates bigger delays downstream. At Serán BioScience, we believe speed and scalability should be designed together from day one. Contact our team to learn more https://lnkd.in/gcBdwsPJ #PharmaceuticalDevelopment #CDMO #CMC #DrugManufacturing #Biopharma

Serán BioScience uses material-sparing approaches and rational drug product design to efficiently bring an enabled formulations into the clinic, allowing the dose flexibility required for early-phase studies without sacrificing the robust product design expected for a commercial product. Watch Micah Tuttle's presentation to learn more: https://lnkd.in/gZDg2qmi #amorphousdispersion #drugproduct #dosageform #cdmo #spraydrying

Can your formulation strategy survive scale-up? “Fast” formulation development is meaningless if the process breaks later. Biotech teams today are under pressure to: • Reach IND faster • Conserve API • Reduce burn • Generate clinical data quickly But compressing timelines without considering commercial manufacturability often creates bigger delays downstream. At Serán BioScience, we believe speed and scalability should be designed together from day one. Contact our team to learn more https://lnkd.in/g-6E5D4V #PharmaceuticalDevelopment #CDMO #CMC #DrugManufacturing #Biopharma

Serán BioScience’s “Right from the Start™” paradigm accelerates pharmaceutical timelines by delivering commercially relevant formulations for First-in-Human (FIH) just six months after candidate selection. By utilizing material-sparing bench work and predictive modeling, Serán defines the manufacturing design space early, avoiding the need for costly reformulations or bridging studies later in development. Read our latest article summarizing our material sparing approach: https://lnkd.in/giYpFc32 By establishing this technical understanding at the milligram-to-gram scale, Serán provides clinical velocity while ensuring a clear line of sight to a robust, scalable commercial product. #CDMO #processdevelopment #drugdevelopment #PharmaCMC

Can your formulation strategy survive scale-up? “Fast” formulation development is meaningless if the process breaks later. Biotech teams today are under pressure to: • Reach IND faster • Conserve API • Reduce burn • Generate clinical data quickly But compressing timelines without considering commercial manufacturability often creates bigger delays downstream. At Serán BioScience, we believe speed and scalability should be designed together from day one. Contact our team to learn more https://lnkd.in/gszxtdWA #PharmaceuticalDevelopment #CDMO #CMC #DrugManufacturing #Biopharma

At Serán BioScience, we prioritize commercial-ready thinking from day one. Our approach integrates scientific rigor with an optimal CMC strategy, resulting in: ✔️Shorter timelines ✔️ Lower costs ✔️Better outcomes for patients Learn more: https://lnkd.in/grYGwPJC #PharmaInnovation #CMCStrategy #DrugDevelopment #Seran

Many oral drug programs fail because manufacturability gets treated as a “later” problem. A formulation can look promising in early development, and then unravel during: • Scale-up & Tech transfer • Stability • Clinical supply expansion • Commercial process design The result? Additional studies. New timelines. Burned API. Lost momentum. At Serán BioScience, we focus on building scalable oral solid dose programs right from the start, specializing in complex and poorly soluble molecules. We develop robust formulations that avoid downstream surprises that can become expensive quickly. That’s why development strategy matters as much as formulation strategy. Connect with our team to learn more. https://lnkd.in/dQyvuE5B #CDMO #processdevelopment #drugdevelopment #drugformulation #PharmaCMC

Many oral drug programs fail because manufacturability gets treated as a “later” problem. A formulation can look promising in early development, and then unravel during: • Scale-up & Tech transfer • Stability • Clinical supply expansion • Commercial process design The result? Additional studies. New timelines. Burned API. Lost momentum. At Serán BioScience, we focus on building scalable oral solid dose programs right from the start, specializing in complex and poorly soluble molecules. We develop robust formulations that avoid downstream surprises that can become expensive quickly. That’s why development strategy matters as much as formulation strategy. Connect with our team to learn more. https://lnkd.in/g6ZUAQWh #CDMO #processdevelopment #drugdevelopment #drugformulation #PharmaCMC

Excited to see our partnership with Mortenson delivering at full speed! Ten months in and Serán BioScience's new commercial manufacturing facility in Bend, Oregon, is already fully enclosed on an accelerated schedule. Designed for advanced spray drying, and scalable commercial production for oral drug products, it will enable us to deliver high-quality, life-changing therapies faster and more reliably for our partners. If your organization has a commercial-ready product (or late-stage candidate) that could benefit from our specialized capabilities in formulation, drug delivery, and commercial-scale manufacturing, we’d love to discuss reserving capacity. Serán is building not just a facility, but a reliable partner for your commercial success. Reach out. https://lnkd.in/gsDzRsWH A huge thank you to the Mortenson team for sharing this impressive video! #SeranBioscience #PharmaManufacturing #DrugDevelopment #CDMO